DaylightGov

H.R. 2450 · 119th Congress · Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Prescription Drug Transparency and Affordability Act

We have not deep-analyzed this bill yet.

Here is what Congress.gov shows.

Sponsor
Rep. McDonald Rivet, Kristen [D-MI-8] (D-MI), House
Cosponsors
3 cosponsors
  • Rep. Carter, Earl L. "Buddy" [R-GA-1] (R-GA)
  • Rep. James, John [R-MI-10] (R-MI)
  • Rep. Menendez, Robert [D-NJ-8] (D-NJ)
Introduced
March 27, 2025
Latest action
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (March 27, 2025)
Scanned
August 26, 2026
Read the bill text on Congress.gov

Public record

Below is the official voting record from Congress.gov. It is not our analysis.

Source: Congress.gov

This bill has no recorded roll-call vote yet. A roll-call vote records how each member voted by name.